C. Hammerman

发表

Tale of Two Patent Ductus Arteriosus Severity Scores: Similarities and Differences

P. McNamara, D. Fink, A. El-Khuffash, 2017, American Journal of Perinatology.

The use of intramuscular glucagon to prevent IV glucose infusion in early neonatal hypoglycemia

F. Mimouni, C. Hammerman, A. Bin-Nun, 2021, Journal of Perinatology.

Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes.

D. Stevenson, E. Beutler, C. Hammerman, 2001, The Journal of pediatrics.

Dual Therapy vs. Monotherapy for the Patent Ductus Arteriosus: A Systematic Review

F. Mimouni, I. Nitzan, C. Hammerman, 2022, Pediatric Cardiology.

Early breast expression for very low birth infants admitted to neonatal intensive care unit: the challenges of cesarean deliveries

F. Mimouni, C. Hammerman, A. Bin-Nun, 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants

C. Hammerman, D. Turner, B. Rudensky, 2006, Acta paediatrica.

Upper Lip Tie and Breastfeeding: A Systematic Review.

F. Mimouni, C. Hammerman, A. Bin-Nun, 2019, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Heterozygosity for a polymorphism in the promoter region of the UGT1A1 gene.

E. Beutler, C. Hammerman, M. Kaplan, 2001, Journal of hepatology.

Immature sucking patterns in infants of mothers with diabetes.

B. Medoff‐Cooper, C. Hammerman, M. Schimmel, 2006, The Journal of pediatrics.

Ischemia and reperfusion injury. The ultimate pathophysiologic paradox.

C. Hammerman, M. Kaplan, 1998, Clinics in perinatology.

The incidence of congenital heart defects in very low birth weight and extremely low birth weight infants.

C. Hammerman, M. Schimmel, A. Nir, 2010, The Israel Medical Association journal : IMAJ.

The mortality of very low birth weight infants: the benefit and relative impact of changes in population and therapeutic variables

A. Samueloff, V. Boyko, B. Reichman, 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

A Systematic Review of Paracetamol and Closure of Patent Ductus Arteriosus: Ready for Prime Time?

F. Mimouni, C. Hammerman, A. Bin-Nun, 2015 .

Hypoxic vs septic pulmonary hypertension. Selective role of thromboxane mediation.

C. Hammerman, K. Komar, H. Abu-Khudair, 1988, American journal of diseases of children.

Germ warfare: probiotics in defense of the premature gut.

C. Hammerman, A. Bin-Nun, M. Kaplan, 2004, Clinics in perinatology.

Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.

C. Hammerman, 1995, Clinics in perinatology.

Probiotics and neonatal intestinal infection

C. Hammerman, M. Kaplan, 2006, Current opinion in infectious diseases.

Correlation of Bacterial Type and Antibiotic Sensitivity with Maternal Antibiotic Exposure in Early-Onset Neonatal Sepsis

C. Hammerman, Y. Schlesinger, M. Schimmel, 2012, Neonatology.

Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram

C. Hammerman, C. Goia, B. Rudensky, 2006, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Hemolysis and bilirubin conjugation in association with UDP‐glucuronosyltransferase 1A1 promoter polymorphism

D. Stevenson, C. Hammerman, E. Levy-Lahad, 2002, Hepatology.

Neonatal Hyperbilirubinemia in Glucose-6-Phosphate Dehydrogenase-deficient Heterozygotes

D. Stevenson, E. Beutler, C. Hammerman, 1999, Pediatrics.

Neonatal bilirubin production, reflected by carboxyhaemoglobin concentrations, in Down’s syndrome

D. Stevenson, C. Hammerman, H. Vreman, 1999, Archives of disease in childhood. Fetal and neonatal edition.

The effects of maternal age and parity on maternal and neonatal outcome

A. Samueloff, C. Hammerman, M. Schimmel, 2015, Archives of Gynecology and Obstetrics.

Safety of probiotics: comparison of two popular strains

C. Hammerman, A. Bin-Nun, M. Kaplan, 2006, BMJ : British Medical Journal.

Hypercapnia: A Potential Culprit in Gray Matter Injury in Preterm Neonates?

C. Hammerman, Yair Kasirer, Alona Bin Nun, 2022, Neuropediatrics.

The effect of patent ductus arteriosus on pre-ductal and post-ductal perfusion index in preterm neonates

M. Nitzan, D. Fink, I. Nitzan, 2018, Physiological measurement.

Prostanoids in neonates with persistent pulmonary hypertension.

C. Hammerman, K. Bui, E. Strates, 1987, The Journal of pediatrics.

Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.

C. Hammerman, B. Rudensky, M. Kaplan, 1997, Clinical chemistry.

The Effect of Meconium Staining of Amniotic Fluid on the Growth of Escherichia coli and Group B Streptococcus

A. Eidelman, D. Raveh, C. Hammerman, 2002, Journal of Perinatology.

Neonatal Polycythemia and Hypoglycemia in Newborns: Are They Related?

F. Mimouni, C. Hammerman, A. Bin-Nun, 2020, American Journal of Perinatology.

Phototherapy and Photo-Oxidation in Premature Neonates

D. Stevenson, C. Hammerman, A. Hochman, 2005, Neonatology.

Protective Effect of Bilirubin in Ischemia-Reperfusion Injury in the Rat Intestine

A. Eidelman, M. Caplan, C. Hammerman, 2002, Journal of pediatric gastroenterology and nutrition.

Association of parental consanguinity with congenital malformations among Arab newborns in Jerusalem

Y. Amitai, C. Hammerman, R. Gofin, 2004, Clinical genetics.

Infants with bilirubin levels of 30 mg/dL or more.

C. Hammerman, M. Kaplan, 2004, Pediatrics.

Effect of rewarming in oxygenation and respiratory condition after neonatal exposure to moderate therapeutic hypothermia.

I. Nitzan, C. Hammerman, A. Bin-Nun, 2019, Pediatrics and neonatology.

Antenatal presentation of carnitine palmitoyltransferase II deficiency.

Ann Saada, A. Shaag, O. Elpeleg, 2001, American journal of medical genetics.

Rapid Fecal Calprotectin (FC) Analysis: Point of Care Testing for Diagnosing Early Necrotizing Enterocolitis

C. Hammerman, A. Bin-Nun, N. Algur, 2014, American Journal of Perinatology.

Elevated Nucleated Red Blood Cells at Birth Predict Hemodynamically Significant Patent Ductus Arteriosus.

D. Fink, F. Mimouni, C. Hammerman, 2016, The Journal of pediatrics.

Recent Developments in the Management of Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2000 .

The Saga of Pulse Oximetry Screening for Critical Congenital Heart Disease in Israel: A Historical Perspective.

F. Mimouni, C. Hammerman, A. Bin-Nun, 2021, The Israel Medical Association journal : IMAJ.

Ibuprofen Versus Continuous Indomethacin in Premature Neonates With Patent Ductus Arteriosus: Is the Difference in the Mode of Administration?

C. Hammerman, M. Schimmel, A. Nir, 2008, Pediatric Research.

Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant.

C. Hammerman, K. Bui, E. Strates, 1987, Developmental pharmacology and therapeutics.

Patent Ductus Arteriosus in the Premature Neonate

C. Hammerman, M. Kaplan, 1999 .

Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus.

C. Hammerman, M. Aramburo, M. J. Aramburo, 1990, The Journal of pediatrics.

Safety assessment of probiotics for human use

J. Heimbach, D. Haller, L. Akkermans, 2010, Gut microbes.

Population-based trends in mortality and neonatal morbidities among singleton, very preterm, very low birth weight infants over 16 years.

A. Samueloff, V. Boyko, B. Reichman, 2014, Early human development.

Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.

C. Hammerman, M. Kaplan, 2004, Seminars in perinatology.

Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.

D. Stevenson, J. Hoyer, C. Hammerman, 2004, Pediatrics.

Glucose-6-phosphate dehydrogenase-deficient neonates: A potential cause for concern in North America.

C. Hammerman, M. Kaplan, M. Kaplan, 2000, Pediatrics.

Effects of Hyperventilation on Prostacyclin Formation and on Pulmonary Vasodilation after Group B β-Hemolytic Streptococci-Induced Pulmonary Hypertension

C. Hammerman, M. J. Aramburo, 1991, Pediatric Research.

Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates.

C. Hammerman, O. Megged, N. Algur, 2015, The Journal of pediatrics.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

M. Caplan, M. Wilschanski, C. Hammerman, 2005, The Journal of pediatrics.

Cerebral Blood Flow Velocity Asymmetry, Neurobehavioral Maturation, and the Cognitive Development of Premature Infants Across the First Two Years

A. Eidelman, C. Hammerman, R. Feldman, 2007, Journal of developmental and behavioral pediatrics : JDBP.

Prostaglandin levels: Predictors of indomethacin responsiveness

S. Berger, C. Hammerman, A. Aldousany, 1986, Pediatric Cardiology.

Does Early Neonatal Thrombocytopenia Affect Ductal Therapeutic Response to Acetaminophen in Preterm Neonates?

F. Mimouni, C. Hammerman, A. Bin-Nun, 2021, American Journal of Perinatology.

Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity.

A. Eidelman, C. Hammerman, M. Schimmel, 1995, Pediatrics.

Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew.

C. Hammerman, A. Bin-Nun, M. Kaplan, 2012, Seminars in perinatology.

Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

D. Fink, C. Hammerman, M. Schimmel, 2011, Pediatrics.

Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis

P. McNamara, F. Manguso, S. Simons, 2015, Archives of Disease in Childhood: Fetal and Neonatal Edition.

Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study.

A. Samueloff, V. Boyko, B. Reichman, 2012, American journal of obstetrics and gynecology.

Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

A. Lahad, E. Beutler, C. Hammerman, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate

D. Stevenson, R. Wong, C. Hammerman, 2008, Journal of Perinatology.

Association between neonatal hyperbilirubinemia and UDP‐glucuronosyltransferase 1A1 gene polymorphisms

C. Hammerman, M. Kaplan, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience.

C. Hammerman, M. Schimmel, N. Algur, 2007, The Journal of pediatrics.

Prediction of hyperbilirubinemia in near-term and term infants.

A. Fanaroff, D. Stevenson, W. Oh, 2001, Journal of perinatology : official journal of the California Perinatal Association.

Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.

C. Hammerman, M. Kaplan, R. Bromiker, 2014, Seminars in perinatology.

Severe Neonatal Hyperbilirubinemia and Kernicterus: Are These Still Problems in the Third Millennium?

C. Hammerman, M. Kaplan, R. Bromiker, 2011, Neonatology.

Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin.

C. Hammerman, M. Kaplan, 2005, Clinica chimica acta; international journal of clinical chemistry.

Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?

C. Hammerman, M. Kaplan, 2004, Clinics in perinatology.

Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.

C. Hammerman, M. Kaplan, 2002, Seminars in neonatology : SN.

Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates

C. Hammerman, E. Levy-Lahad, P. Renbaum, 2000, The Lancet.

Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice.

D. Stevenson, C. Hammerman, M. Muraca, 2002, Pediatrics.

Femoral hypoplasia--unusual facies syndrome: prenatal ultrasonographic observations.

M. Itzchaki, C. Hammerman, R. Rabinowitz, 1993, Fetal diagnosis and therapy.

Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype.

C. Hammerman, N. Algur, M. Kaplan, 2012, The Journal of pediatrics.

Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.

C. Hammerman, M. Kaplan, 2010, Seminars in fetal & neonatal medicine.

Enzymatic activity in glucose-6-phosphate dehydrogenase-normal and -deficient neonates measured with a commercial kit.

C. Hammerman, B. Rudensky, M. Kaplan, 1995, Clinical chemistry.

Paracetamol Serum Concentrations in Neonates Treated Enterally for Ductal Closure: A Pilot Study

D. Fink, F. Mimouni, C. Hammerman, 2018, The Journal of pediatrics.

Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase.

A. Eidelman, M. Caplan, C. Hammerman, 1999, Journal of pediatric gastroenterology and nutrition.

SMOFlipid Protects Preterm Neonates against Perinatal Nutrition–Associated Cholestasis

F. Mimouni, C. Hammerman, A. Bin-Nun, 2019, American Journal of Perinatology.

Effect of vitamin K1 on glucose-6-phosphate dehydrogenase deficient neonatal erythrocytes in vitro

D. Waisman, C. Hammerman, N. Meyerstein, 1998, Archives of disease in childhood. Fetal and neonatal edition.

MECONIUM STAINED AMNIOTIC FLUID AND BACTERIAL GROWTH A QUANTITATIVE STUDY.† 1790

A. Eidelman, C. Hammerman, M. Schimmel, 1996, Pediatric Research.

HEMOLYSIS AND HYPERBILIRUBINEMIA IN ABO BLOOD GROUP HETEROSPECIFIC NEONATES

D. Stevenson, R. Wong, C. Hammerman, 2010 .

Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates.

C. Hammerman, N. Algur, M. Kaplan, 2001, Pediatrics.

Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome

E. Beutler, C. Hammerman, M. Kaplan, 2001, European Journal of Pediatrics.

Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates.

D. Stevenson, C. Hammerman, M. Schimmel, 1998, Journal of perinatology : official journal of the California Perinatal Association.

The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective

C. Hammerman, M. Kaplan, M. Kaplan, 2009, Journal of Perinatology.

Elevated Nucleated Red Blood Cells in Neonates with Down Syndrome and Pulmonary Hypertension.

D. Fink, F. Mimouni, I. Nitzan, 2019, The Journal of pediatrics.

Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus

C. Hammerman, M. Kaplan, 2001, Drug safety.

Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.

C. Hammerman, M. Kaplan, 1999, Paediatric drugs.

Indomethacin and the Cardiopulmonary Adaptations of Transition

C. Hammerman, E. Scarpelli, 1984, Pediatric Research.

Mildly Elevated Bilirubin Levels are Associated with Increased Magnetic Resonance Imaging Signal Intensity in the Basal Ganglia of Preterm Neonates

C. Hammerman, A. Bin-Nun, Yair Kasirer, 2021, American Journal of Perinatology.

Endogenous dilator prostaglandins in congenital heart disease

C. Hammerman, K. Bui, M. J. Aramburo, 2005, Pediatric Cardiology.

Low Levels of Procalcitonin During Episodes of Necrotizing Enterocolitis

C. Hammerman, D. Turner, A. Muise, 2007, Digestive Diseases and Sciences.

The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.

V. Bhutani, C. Hammerman, M. Kaplan, 2016, Clinics in perinatology.

Parental education and the WHO neonatal G-6-PD screening program: a quarter century later

V. Bhutani, C. Hammerman, M. Kaplan, 2015, Journal of Perinatology.

Hyperbilirubinemia in black infants.

C. Hammerman, M. Kaplan, 2013, Jornal de Pediatria.

Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.

D. Stevenson, G. Heller, J. Hoyer, 2006, The Journal of pediatrics.

Predischarge Bilirubin Screening in Glucose-6-Phosphate Dehydrogenase-Deficient Neonates

C. Hammerman, M. Kaplan, Cathy Hammerman, 2000, Pediatrics.

Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.

C. Hammerman, M. Muraca, M. Vilei, 1996, The Journal of pediatrics.

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.

C. Hammerman, M. Kaplan, 2011, Seminars in perinatology.

(TA)n UDP-Glucuronosyltransferase 1A1 Promoter Polymorphism in Nigerian Neonates

T. Slusher, C. Hammerman, E. Levy-Lahad, 2008, Pediatric Research.

Screening for glucose-6-phosphate dehydrogenase deficiency.

C. Hammerman, M. Kaplan, A. Abramov, 1992, The Journal of pediatrics.

Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.

C. Hammerman, M. Muraca, B. Rudensky, 1998, Pediatrics.

Prediction of Hyperbilirubinemia in Near-Term and Term Infants

A. Fanaroff, D. Stevenson, W. Oh, 2001, Journal of Perinatology.

Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

D. Stevenson, R. Wong, C. Hammerman, 2010, The Journal of pediatrics.

Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia

A. Eidelman, C. Hammerman, M. Schimmel, 2005, Archives of Disease in Childhood.

Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity

D. Stevenson, C. Hammerman, M. Muraca, 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Neonatal Hyperbilirubinemia in the Low-Intermediate–Risk Category on the Bilirubin Nomogram

C. Hammerman, M. Schimmel, A. Bin-Nun, 2012, Pediatrics.

CONTRIBUTION OF HAEMOLYSIS TO JAUNDICE IN SEPHARDIC JEWISH GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENT NEONATES

C. Hammerman, H. Vreman, M. Kaplan, 1996, British journal of haematology.

97 – Hereditary Contribution to Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2017 .

Unconjugated and Conjugated Bilirubin Pigments during Perinatal Development

C. Hammerman, M. Muraca, M. Vilei, 1986, Neonatology.

Onset of jaundice in G6PD deficient neonates.

C. Hammerman, M. Kaplan, 2006, Indian pediatrics.

Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation.

C. Hammerman, M. Kaplan, M. Maisels, 2003, Pediatrics.

Severe hyponatremia with indomethacin--a more serious toxicity than previously realized?

C. Hammerman, W. Zaia, H. H. Wu, 1985, Developmental pharmacology and therapeutics.

(TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates

D. Stevenson, R. Wong, C. Hammerman, 2007, Pediatric Research.

Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity

A. Eidelman, C. Hammerman, M. Schimmel, 1998, Pediatrics.

Third Ventricle Enlargement Among Newborn Infants With Trisomy 21

C. Hammerman, Itai Berger, M. Schimmel, 2006, Pediatrics.

Direct Antiglobulin Titer Strength and Hyperbilirubinemia

D. Stevenson, R. Wong, C. Hammerman, 2014, Pediatrics.

Grand Rounds Hyperbilirubinemia Following Phototherapy In Glucose-6-Phosphate Dehydrogenase Deficient Neonates: Not Out Of The Woods.

C. Hammerman, S. Shapiro, M. Kaplan, 2023, The Journal of pediatrics.

Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials.

C. Hammerman, M. Kaplan, 2020, Neonatology.

Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates.

D. Stevenson, J. Hoyer, T. Karrison, 2006, Clinica chimica acta; international journal of clinical chemistry.

Differing Pathogenesis of Perinatal Bilirubinemia in Glucose-6-Phosphate Dehydrogenase-Deficient Versus-Normal Neonates

D. Stevenson, C. Hammerman, E. Levy-Lahad, 2001, Pediatric Research.

Comparative measurements of phototherapy: a practical guide.

A. Eidelman, C. Hammerman, L. Gartner, 1981, Pediatrics.

Arteriosus Treatment Ductal Closure With Paracetamol : A Surprising New Approach to Patent Ductus

D. Fink, C. Hammerman, M. Schimmel, 2011 .

Infant delivery and maternal stress during the COVID-19 pandemic: a comparison of the well-baby versus neonatal intensive care environments

F. Mimouni, C. Hammerman, A. Bin-Nun, 2021, Journal of Perinatology.

EFFECTS OF SEVERE HYPOXIA ON DILATOR PROSTAGLANDIN SYNTHESIS

J. Lieske, C. Hammerman, E. Strates, 1984, Pediatric Research.

Kernicterus on the Spectrum.

C. Hammerman, Yair Kasirer, M. Kaplan, 2023, NeoReviews.

Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants.

F. Mimouni, C. Hammerman, 2017, The Journal of pediatrics.

Decision-making in the critically ill neonate: cultural background v individual life experiences.

A. Eidelman, C. Hammerman, O. Lavie, 1997, Journal of medical ethics.

Bullying in schools: self reported anxiety, depression, and self esteem in secondary school children

E Kornbluth, C. Hammerman, M. Schimmel, 1998, BMJ.

Indomethacin and retinopathy of prematurity: the hidden paradox.

C. Hammerman, 2008, The Journal of pediatrics.

Mitral valve Doppler for cardiac output assessment in preterm neonates

A. Sehgal, S. Menahem, I. Nitzan, 2022, Echocardiography.

Early neonatal pyloric stenosis after exposure to maternal macrolide therapy

E. Picard, C. Hammerman, M. Schimmel, 2016 .

Combination of ABO blood group incompatibility and glucose‐6‐phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia

C. Hammerman, B. Rudensky, M. Kaplan, 1998, Acta paediatrica.

Glucose-6-phosphate dehydrogenase deficiency.

C. Hammerman, M. Kaplan, 1995, Postgraduate medical journal.

Increased parity and risk of trisomy 21: review of 37 110 live births

C. Hammerman, M. Schimmel, P. Zadka, 1997, BMJ.

A simple noninvasive biomarker can reflect both the acute and chronic pulmonary impact of patent ductus arteriosus shunting

F. Mimouni, C. Hammerman, A. Bin-Nun, 2022, Pediatric pulmonology.

Hypocalcemia and the patent ductus arteriosus.

A. Eidelman, C. Hammerman, L. Gartner, 1979, The Journal of pediatrics.

N-terminal-Pro-B-Type Natriuretic Peptide in Premature Patent Ductus Arteriosus: A Physiologic Biomarker, But Is It a Clinical Tool?

C. Hammerman, M. Schimmel, A. Nir, 2009, Pediatric Cardiology.

Phototherapy light combinations.

A. Eidelman, C. Hammerman, 1979, The Journal of pediatrics.

Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates

D. Fink, F. Mimouni, I. Nitzan, 2018, Journal of Perinatology.

Does pregnancy affect medical ethical decision making?

A. Eidelman, C. Hammerman, O. Lavie, 1998, Journal of Medical Ethics.

Letter to The Editor

C. Hammerman, M. Kaplan, 2000, Journal of Perinatology.

Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy.

D. Stevenson, C. Hammerman, H. Vreman, 1996, Biology of the neonate.

Might Bilirubin Serve as a Natural Antioxidant in Response to Neonatal Encephalopathy?

F. Mimouni, C. Hammerman, M. Schimmel, 2018, American Journal of Perinatology.

Heme Oxygenase-1 Promoter Polymorphisms and Neonatal Jaundice

D. Stevenson, R. Wong, C. Hammerman, 2014, Neonatology.

The silent ductus: Its precursors and its aftermath

C. Hammerman, E. Strates, S. Valaitis, 2006, Pediatric Cardiology.

Indomethacin and apnea of prematurity.

C. Hammerman, D. Zangen, 1993, Critical care medicine.

Hyperbilirubinemia in the Term Infant: Re-evaluating What We Think We Know.

C. Hammerman, M. Kaplan, 2021, Clinics in perinatology.

Glucose-6-phosphate dehydrogenase activity in male premature and term neonates

C. Hammerman, D. Bader, B. Rudensky, 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Visual screening versus transcutaneous bilirubinometry for predischarge jaundice assessment

C. Hammerman, M. Schimmel, N. Algur, 2008, Acta paediatrica.

Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials

C. Hammerman, 2008 .

Failure to Predict Hemolysis and Hyperbilirubinemia by IgG Subclass in Blood Group A or B Infants Born to Group O Mothers

D. Stevenson, R. Wong, C. Hammerman, 2009, Pediatrics.

Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates.

D. Stevenson, J. Hoyer, C. Hammerman, 2005, Clinica chimica acta; international journal of clinical chemistry.

Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis?

C. Hammerman, M. Kaplan, D. Stevenson, 1996, Acta paediatrica.

Elective High-Frequency Oscillatory Ventilation versus Conventional Ventilation for Acute Pulmonary Dysfunction in Preterm Infants

Sung-il Cho, W. Hop, N. Marlow, 2012, Neonatology.

Unconjugated and conjugated bilirubin pigments during perinatal development. V. Effect of phototherapy on serum conjugated bilirubin in hyperbilirubinemic neonates.

C. Hammerman, M. Muraca, M. Vilei, 1998, Biology of the neonate.

Bilirubin in the premature: toxic waste or natural defense?

Hammerman, A. Eidelman, C. Hammerman, 1998, Clinical chemistry.

Twin pregnancy in a patient after the Fontan operation: report of a case.

C. Hammerman, A. Rein, U. Elchalal, 2013, Congenital Heart Disease.

Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.

C. Hammerman, M. Kaplan, Cathy Hammerman, 1998, Clinics of Perinatology.

Direct Antiglobulin Titer Strength and Hyperbilirubinemia

D. Stevenson, R. Wong, C. Hammerman, 2014, Pediatrics.

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

M. Caplan, M. Wilschanski, C. Hammerman, 2005, The Journal of pediatrics.

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: sex distribution.

C. Hammerman, B. Rudensky, A. Abramov, 1994, Archives of disease in childhood. Fetal and neonatal edition.

Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study.

A. Samueloff, V. Boyko, B. Reichman, 2012, American journal of obstetrics and gynecology.

Deciding Who Lives

Cathy Hammerman, C. Hammerman, 1998 .

Detection of Global Brain Injury Using Point-of-Care Neonatal MRI Scanner

C. Hammerman, R. Cytter-Kuint, A. Bin-Nun, 2021, Neuropediatrics.

Exchange transfusion for neonatal hyperbilirubinemia with glucose ‑ 6 ‑ phosphate ‑ deficient blood

C. Hammerman, M. Kaplan, 2009 .

American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus

C. Hammerman, M. Kaplan, 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

Very low-birth-weight-infants conceived by in vitro fertilization are not at higher risk for mortality and morbidity: a population-based study.

A. Lusky, B. Reichman, C. Hammerman, 2006, Fertility and sterility.

N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

E. Picard, C. Hammerman, Efrat Ben Shalom, 2010, American journal of perinatology.

Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment

D. Fink, C. Hammerman, M. Schimmel, 2011, Pediatrics.

Wide Pulse Pressure Is Not Associated with Patent Ductus Arteriosus in the First Week of Life

D. Fink, F. Mimouni, C. Hammerman, 2019, American Journal of Perinatology.

Controversies in our understanding of extreme hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient neonates.

C. Hammerman, Yair Kassirer, M. Kaplan, 2024, Pediatric research.

Familial hyperbilirubinemia in ABO-incompatible neonates.

C. Hammerman, M. Kaplan, 2003, Pediatrics.

Glucose-6-Phosphate Dehydrogenase Deficiency: A Worldwide Potential Cause of Severe Neonatal Hyperbilirubinemia

C. Hammerman, M. Kaplan, 2000 .